Technical Analysis for HOOK - HOOKIPA Pharma Inc.

Grade Last Price % Change Price Change
grade C 8.28 -1.19% -0.10
HOOK closed up 8.55 percent on Thursday, October 17, 2019, on 1.9 times normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Up Up
See historical HOOK trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish -1.19%
Expansion Pivot Buy Setup Bullish Swing Setup -1.19%
Pocket Pivot Bullish Swing Setup -1.19%
Wide Range Bar Range Expansion -1.19%
Above Upper BB Strength -1.19%
Up 3 Days in a Row Strength -1.19%
Upper Bollinger Band Touch Strength -1.19%
Crossed Above 20 DMA Bullish 7.25%
Crossed Above 50 DMA Bullish 7.25%
MACD Bullish Signal Line Cross Bullish 7.25%

Older signals for HOOK ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
HOOKIPA Pharma Inc., a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop arenavirus based therapeutics to treat hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York.
Biotechnology Biopharmaceutical Cancer Life Sciences Infectious Diseases Cancers Transplantation Gilead Sciences Immunotherapeutics Viral Disease
Is HOOK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 14.76
52 Week Low 6.06
Average Volume 25,819
200-Day Moving Average 0.0
50-Day Moving Average 7.5292
20-Day Moving Average 7.321
10-Day Moving Average 7.056
Average True Range 0.471
ADX 17.71
+DI 37.7436
-DI 17.2837
Chandelier Exit (Long, 3 ATRs ) 7.036999999999999
Chandelier Exit (Short, 3 ATRs ) 7.913
Upper Bollinger Band 8.38
Lower Bollinger Band 6.262
Percent B (%b) 1.0
BandWidth 28.930474
MACD Line -0.0659
MACD Signal Line -0.1737
MACD Histogram 0.1077
Fundamentals Value
Market Cap 157.98 Million
Num Shares 18.9 Million
EPS 0.47
Price-to-Earnings (P/E) Ratio 17.94
Price-to-Sales 0.84
Price-to-Book 1.17
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.81
Resistance 3 (R3) 9.67 9.06 9.57
Resistance 2 (R2) 9.06 8.70 9.13 9.49
Resistance 1 (R1) 8.72 8.47 8.89 8.86 9.41
Pivot Point 8.11 8.11 8.20 8.18 8.11
Support 1 (S1) 7.77 7.75 7.94 7.91 7.35
Support 2 (S2) 7.16 7.52 7.23 7.27
Support 3 (S3) 6.82 7.16 7.19
Support 4 (S4) 6.96